XTNT · Annual Report (Form 10-K) · Filed March 31, 2026

Xtant Medical Holdings Inc — 10-K exhibit

ex10-40.htm

Xtant Medical Holdings Inc on Boardroom Alpha

Exhibit 10.40

Lease Modification Agreement

This Lease Modification Agreement (the “Agreement”), made and entered into this

8 day of September, 2025, by and between Step Does Stuff LLC (the “Landlord”) and Bacterin International, Inc., now known as Xtant Medical, Inc., (the “Tenant”) and is in accordance with and subject to the terms of the Commercial Lease dated October 23, 2015 (the “Lease”) between Step Does Stuff and Xtant Medical, Inc.

WITNESSETH:

Whereas, under the Lease, Landlord leased to Tenant the premises located at 664 Cruiser Lane, Belgrade, MT 59714, as more particularly described in the Lease and on the terms and conditions set out therein, and;

Whereas, Tenant and Landlord desire to modify and amend the Lease terms and conditions as set forth herein.

Now, therefore, in consideration of the promises, covenants and agreements hereinafter set out, the parties hereby agree as follows:

1. Term: Tenant hereby wishes to exercise its Renewal Option as follows:

A 5-year renewal is hereby implemented that extends the Lease to October 31, 2030 (the “First Five Year Option”).

2. Rent: The rental cost for the Extended Term shall proceed as proscribed in the Lease.

3. Force and Effect: Except as expressly modified and amended by this Agreement, all other terms and conditions of the Lease continue and shall remain in full force and effect.

IN WITNESS WHEREOF, the parties have caused this Agreement to be executed in duplicate by their duly authorized representatives.

Scott Olsen, Member		Scott Neils, CFO
Shep Does Stuff LLC		Xtant Medical, Inc.

Name:	/s/ Scott Olsen	Name:	Scott Neils
Date:	Sept 25, 2025	Date:	09/08/2025

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer